SkyePharma
SkyePharma PLC Announces Intent to Delist from the NASDAQ Stock Market and to Deregister and Terminate its Reporting Obligations under the U.S. Securities Exchange Act of 1934
Published in Healthcare Mergers, Acquisitions and Ventures Week, May 26th, 2007
SkyePharma PLC (LSE: SKP; NASDAQ: SKYE) announced today that it will delist its American Depositary Shares (the 'ADSs'), each representing the right to receive ten ordinary shares of ten pence each of SkyePharma, from The NASDAQ Stock Market and, pursuant to the newly-adopted Rule 12h-6(a) under the U.S. Securities Exchange Act of 1934 (the 'Exchange Act'), deregister and terminate SkyePharma's reporting obligations under Sections 13(a) and 15(d) of Exchange Act.
SkyePharma's Board of Directors authorized this action based on its assessment that (a) continued compliance with the rules of the U.S. Securities Exchange Commission ('SEC') and NASDAQ, in particular Section...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- AARP
AARP Rolls Up Their Sleeves Nationwide, Gives Back to Local Communities - Abbott
Abbott Highlights Strong Performance in Corporate Social Responsibility in 2006 Global Citizenship Report - Abraxis BioScience, Inc.
Abraxis BioScience Reports First Quarter 2007 Revenue of $212.2 Million Versus $144.5 Million in Prior Year Period - Abt Associates
Abt Associates' Richard A. Kulka Elected President-elect of American Association for Public Opinion Research - Abt Associates
Constantin Abarbieritei To Lead Abt Associates' International Economic Growth Division - Acambis
Ian Garland joins Acambis as new CEO - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
